查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球诊断心电图 (ECG) 市场：按产品/服务、引线类型、最终用户、地区划分 - 到 2028 年的预测
市场调查报告书
商品编码
1342757

全球诊断心电图 (ECG) 市场：按产品/服务、引线类型、最终用户、地区划分 - 到 2028 年的预测

Diagnostic Electrocardiograph (ECG) Market by Product (Resting ECG, Stress, Mobile Cardiac Telemetry Device, Implantable Loop Recorder) and Service, Lead Type (12-lead, 6-lead, 5- lead), End User, and Region - Global Forecast to 2028
出版日期: | 出版商: MarketsandMarkets | 英文 176 Pages | 订单完成后即时交付

价格
简介目录

全球诊断心电图机 (ECG) 市场规模预计将从 2023 年的 81 亿美元增至 2028 年的 113 亿美元，预测期内年复合成长率为 6.9%。

心血管和生活方式相关疾病的盛行率不断上升，对心臟病早期诊断的需求不断增加，穿戴式心电图设备的技术进步，人口高龄化比例不断增加，医疗保健基础设施不断增加，以及对全球诊断心电图製造商的需求不断增加。因素，例如不断增长的地理影响。

按产品类型划分，诊断心电图市场分为设备和软体服务。设备部分分为静止心电图设备、负载心电图设备、动态心电图监测仪、事件监测仪、植入式动态心电图监测仪、行动心臟遥测设备和智慧心电图设备。 2022年，静息心电图设备领域在诊断心电图市场中占最大份额。这是要素经济高效的静息心电图设备的可用性不断增加以及静息心电图设备在医院环境中的广泛采用。

依导极类型，诊断心电图 (ECG) 市场分为贴片式 12 导程、5 导程、3 导程、6 导程、单导极和其他导极类型（13 导程、18 导联等） .)。 2022年，12导联型在诊断心电图市场中占据最大份额。 12 导程心电图设备可提供高度详细的预测，并有助于解释心电活动。

按最终用户划分，诊断心电图 (ECG) 市场分为医院、诊所、心臟中心、门诊手术中心和其他最终用户。由于心血管疾病盛行率不断上升、心臟中心的建立以及医院提供的服务的扩大和改善，医院、诊所和饭店中心细分市场在 2022 年占据全球市场的最大份额。

该报告考察了全球诊断心电图 (ECG) 市场，并按产品/服务、引线类型、最终用户、地区和进入市场的公司概况总结了趋势。

目录

第1章简介

第2章调查方法

第3章执行摘要

第4章重要考察

第5章市场概况

  • 介绍
  • 市场动态
  • 价格分析
  • 专利分析
  • 价值链分析
  • 供应链分析
  • 生态系分析
  • 波特五力分析
  • 赎回场景
  • 法规分析
  • 贸易分析
  • 技术分析
  • 2023-2024年重大会议和活动
  • 影响客户业务的趋势/干扰
  • 主要相关人员和采购标准

第6章诊断心电图市场（依产品）

  • 介绍
  • 装置
  • 软体和服务

第7章诊断心电图市场（依导极类型）

  • 介绍
  • 12 条线索
  • 5 条线索
  • 3 条线索
  • 6 导联
  • 单导联
  • 其他的

第8章诊断心电图市场（依最终用户）

  • 介绍
  • 医院、诊所、心臟中心
  • 门诊手术中心
  • 其他的

第9章诊断心电图市场，依地区

  • 介绍
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第10章竞争形势

  • 概述
  • 主要参与企业所采取的策略
  • 收入份额分析
  • 市占率分析
  • 主要企业企业评价矩阵
  • 新创公司/中小企业的企业评估矩阵
  • 竞争标竿管理
  • 竞争情境（2020-2023）

第11章公司简介

  • 主要参与企业
    • GE HEALTHCARE
    • KONINKLIJKE PHILIPS NV
    • HILL-ROM HOLDINGS, INC.（BAXTER INTERNATIONAL INC.）
    • FUKUDA DENSHI
    • MINDRAY MEDICAL INTERNATIONAL LIMITED
    • NIHON KOHDEN CORPORATION
    • OSI SYSTEMS, INC.
    • BPL MEDICAL TECHNOLOGIES
    • SCHILLER AG
    • BITTIUM
    • ACS DIAGNOSTICS
    • ALLENGERS MEDICAL SYSTEMS LTD.
    • BIONET
    • CARDIAC INSIGHT, INC.
    • BTL
  • 其他公司
    • MEDITECH EQUIPMENT CO. LTD.
    • MIDMARK CORPORATION
    • ALIVECOR, INC.
    • VITALCONNECT
    • IRHYTHM TECHNOLOGIES, INC.
    • BORSAM BIOMEDICAL INSTRUMENTS CO., LTD.
    • NASIFF ASSOCIATES, INC.
    • VECTRACOR
    • BIOMEDICAL INSTRUMENTS CO. LTD.
    • LIFESIGNALS, INC.

第12章附录

简介目录
Product Code: MD 2551

The global diagnostic electrocardiogram (ECG) market is projected to reach USD 11.3 billion by 2028 from USD 8.1 billion in 2023, at a CAGR of 6.9% during the forecast period. The rising prevalence of cardiovascular and lifestyle diseases, growing demand for early cardiac diseases diagnosis , technological advancements in wearable ECG devices, increasing proportion of aging population, increasing healthcare infrastructure and growing geographical presence of diagnostic ECG manufacturers globally.

"Resting ECG Devices segment to dominate diagnostic electrocardiogram (ECG) market during the forecast period."

Based on product type, the diagnostic ECG market is segmented into devices and software & Services . The devices segment is categorized into resting ECG devices, stress ECG devices, Holter monitors, event monitors, implantable loop recorders, mobile cardiac telemetry devices, and smart ECG devices. The resting ECG devices segment captured the largest share of diagnostic ECG market in 2022 attributed to the increasing availability of cost effective resting ECG devices and wider adoption of resting ECG devices in hospital settings.

"12 lead , by lead type , accounted for the largest market share of global diagnostic electrocardiogram (ECG) market in 2022."

Based on lead type, the diagnostic electrocardiogram (ECG) market is segmented into patch type 12-lead, 5-lead, 3-lead, 6-lead, single lead, and other lead types (such as 13 lead, 18- lead). In 2022, the 12-lead segment accounted for the largest share of the diagnostic ECG market. This is mainly attributed to higher clarity obtained by using a larger number of leads; 12-lead ECG devices provide a highly detailed outlook, making it easier to interpret cardiac electrical activity.

"The hospitals, clinics, and cardiac centers to dominate the global electrocardiogram ECG market in 2022."

Based on end user, the diagnostic electrocardiogram (ECG) market is segmented into hospitals, clinics, and Cardiac Centers, ambulatory surgical centers, and other end users. The hospitals, clinics, and Cardiac Centers segment accounted for the largest share of the global market in 2022 attributed to the increasing prevalence of cardiovascular diseases, establishment of cardiac centers, and increasing government funding to expand and improve the services offered by hospitals.

"The APAC market, by region, to register highest growth rate in the forecast period."

On the basis of region, the diagnostic electrocardiogram (ECG) market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America holds the largest share and expects to dominate the diagnostic ECG market. The Asia-Pacific market is likely witnessing significant growth owing to increase in disposable income and increase in cardiovascular patient pool. Rising penetration of advanced diagnostic ECG in hospitals, and growing healthcare expenditure

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-48%, Tier 2-36%, and Tier 3- 16%
  • By Designation: C-level-10%, Director-level-14%, and Others-76%
  • By Region: North America-40%, Europe-32%, Asia Pacific-20%, Latin America-5%, MEA- 3%

The prominent players in the diagnostic electrocardiogram (ECG) market are GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Nihon Kohden Corporation (Japan), OSI Systems, Inc. (US), Hill-Rom Holdings, Inc. (Baxter International Inc.) (US), Mindray Medical International Limited (China), SCHILLER AG (Switzerland), Bittium Corporation (Finland), Fukuda Denshi Co., Ltd. (Japan), BPL Medical Technologies Pvt. Ltd. (India), among others.

Research Coverage

This report studies the diagnostic electrocardiogram (ECG) market based on product type, lead type, end-user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.

This report provides insights on the following pointers:

  • Analysis of key drivers ( rising prevalence of cardiovascular diseases, increasing geriatric population growing demand for remote monitoring, technological advancements in wireless ECG devices ) restraints (stringent regulatory approvals delaying the approval of diagnosis ECG devices ), opportunities (rising healthcare expenditure across developing countries, high growth offered by emerging markets), and challenges (lack of skilled professional) influencing the growth of diagnostic electrocardiogram (ECG) market
  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the diagnostic electrocardiogram (ECG) market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the diagnostic electrocardiogram (ECG) market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the diagnostic electrocardiogram (ECG) market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 STUDY SCOPE
    • FIGURE 1 MARKETS COVERED
    • 1.3.1 GEOGRAPHIC SCOPE
    • 1.3.2 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 KEY MARKET STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES
  • 1.7 RECESSION IMPACT ON DIAGNOSTIC ECG MARKET

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY RESEARCH
      • 2.1.2.1 Key data from primary sources
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 4 DIAGNOSTIC ECG MARKET: BREAKDOWN OF PRIMARIES
  • 2.2 MARKET SIZE ESTIMATION METHODOLOGY
    • FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • 2.2.1 PRODUCT-BASED MARKET ESTIMATION
    • 2.2.2 END USER-BASED MARKET ESTIMATION
    • FIGURE 6 MARKET SIZE ESTIMATION: DIAGNOSTIC ECG MARKET
    • 2.2.3 PRIMARY RESEARCH VALIDATION
  • 2.3 DATA TRIANGULATION
    • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • 2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS
    • 2.4.1 RESEARCH ASSUMPTIONS
    • 2.4.2 RESEARCH LIMITATIONS
  • 2.5 RECESSION IMPACT
    • TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021-2027 (% GROWTH)

3 EXECUTIVE SUMMARY

    • FIGURE 8 DIAGNOSTIC ECG MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    • FIGURE 9 DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 10 DIAGNOSTIC ECG MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 11 GEOGRAPHICAL SNAPSHOT OF DIAGNOSTIC ECG MARKET

4 PREMIUM INSIGHTS

  • 4.1 DIAGNOSTIC ECG MARKET OVERVIEW
    • FIGURE 12 INCREASING PREVALENCE OF CVD GLOBALLY TO DRIVE MARKET GROWTH
  • 4.2 NORTH AMERICA: DIAGNOSTIC ECG MARKET SHARE, BY PRODUCT & COUNTRY (2022)
    • FIGURE 13 DEVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN DIAGNOSTIC ECG MARKET IN 2022
  • 4.3 DIAGNOSTIC ECG DEVICES MARKET SHARE, BY TYPE, 2023 VS. 2028
    • FIGURE 14 RESTING ECG DEVICES TO CAPTURE LARGEST SHARE OF DIAGNOSTIC ECG DEVICES MARKET IN 2022
  • 4.4 DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 15 12-LEAD ECG DEVICES SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2028
  • 4.5 DIAGNOSTIC ECG MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 16 HOSPITALS, CLINICS, AND CARDIAC CENTERS SEGMENT TO DOMINATE MARKET IN 2028
  • 4.6 DIAGNOSTIC ECG MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH IN DIAGNOSTIC ECG MARKET FROM 2023 TO 2028

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 18 DIAGNOSTIC ECG MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing incidence of lifestyle and cardiovascular diseases
      • 5.2.1.2 Rapidly expanding global geriatric population and subsequent surge in heart conditions
      • 5.2.1.3 Development of wireless monitoring and wearable cardiac devices
      • 5.2.1.4 Increasing investments, funds, and grants for research on cardiac diagnosis
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Stringent regulatory requirements delaying approval of cardiac devices
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emerging markets to offer high-growth opportunities
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Dearth of skilled professionals
  • 5.3 PRICING ANALYSIS
    • TABLE 2 AVERAGE SELLING PRICE OF DIAGNOSTIC ECG MONITORING PRODUCTS (2022)
  • 5.4 PATENT ANALYSIS
    • FIGURE 19 PATENT ANALYSIS FOR DIAGNOSTIC ECG MARKET
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 20 VALUE CHAIN ANALYSIS OF DIAGNOSTIC ECG MARKET: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
  • 5.6 SUPPLY CHAIN ANALYSIS
    • FIGURE 21 DIAGNOSTIC ECG MARKET: SUPPLY CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
    • FIGURE 22 DIAGNOSTIC ECG MARKET: ECOSYSTEM ANALYSIS
  • 5.8 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 3 DIAGNOSTIC ECG MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.8.1 THREAT OF NEW ENTRANTS
    • 5.8.2 THREAT OF SUBSTITUTES
    • 5.8.3 BARGAINING POWER OF BUYERS
    • 5.8.4 BARGAINING POWER OF SUPPLIERS
    • 5.8.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.9 REIMBURSEMENT SCENARIO
    • TABLE 4 CPT CODES FOR ECG PROCEDURES
  • 5.10 REGULATORY ANALYSIS
    • TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 8 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 9 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.10.1 NORTH AMERICA
      • 5.10.1.1 US
      • 5.10.1.2 Canada
    • 5.10.2 EUROPE
    • 5.10.3 ASIA PACIFIC
      • 5.10.3.1 China
      • 5.10.3.2 Japan
      • 5.10.3.3 India
    • 5.10.4 LATIN AMERICA
      • 5.10.4.1 Brazil
      • 5.10.4.2 Mexico
    • 5.10.5 MIDDLE EAST
    • 5.10.6 AFRICA
  • 5.11 TRADE ANALYSIS
    • 5.11.1 TRADE ANALYSIS FOR DIAGNOSTIC ECG PRODUCTS
    • TABLE 10 IMPORT DATA FOR DIAGNOSTIC ECG PRODUCTS, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 11 EXPORT DATA FOR DIAGNOSTIC ECG PRODUCTS, BY COUNTRY, 2018-2022 (USD MILLION)
  • 5.12 TECHNOLOGY ANALYSIS
  • 5.13 KEY CONFERENCES & EVENTS, 2023-2024
    • TABLE 12 DIAGNOSTIC ECG MARKET: DETAILED LIST OF CONFERENCES & EVENTS
  • 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • 5.14.1 REVENUE SHIFT AND REVENUE POCKETS FOR DIAGNOSTIC ECG MONITOR MANUFACTURERS
    • FIGURE 23 REVENUE SHIFT IN DIAGNOSTIC ECG MARKET
  • 5.15 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR DIAGNOSTIC ECG PRODUCTS
    • TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR DIAGNOSTIC ECG PRODUCTS
    • 5.15.2 BUYING CRITERIA
    • FIGURE 25 KEY BUYING CRITERIA FOR DIAGNOSTIC ECG PRODUCTS
    • TABLE 14 KEY BUYING CRITERIA FOR DIAGNOSTIC ECG PRODUCTS

6 DIAGNOSTIC ECG MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 15 DIAGNOSTIC ECG MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • 6.2 DEVICES
    • TABLE 16 DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 6.2.1 RESTING ECG DEVICES
      • 6.2.1.1 Wide availability of resting ECG devices to support market growth
    • TABLE 17 RESTING ECG DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.2 STRESS ECG DEVICES
      • 6.2.2.1 High cost of stress ECG devices to limit adoption
    • TABLE 18 STRESS ECG DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.3 HOLTER MONITORS
      • 6.2.3.1 Growing demand for continuous monitoring to fuel growth
    • TABLE 19 HOLTER MONITORS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.4 EVENT MONITORS
      • 6.2.4.1 Increasing outsourcing of monitoring devices to propel market growth
    • TABLE 20 EVENT MONITORS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.5 IMPLANTABLE LOOP RECORDERS
      • 6.2.5.1 Introduction of technologically advanced implantable loop recorders to support market growth
    • TABLE 21 IMPLANTABLE LOOP RECORDERS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.6 MOBILE CARDIAC TELEMETRY DEVICES
      • 6.2.6.1 Increasing demand for cardiac monitoring solutions in home care settings to propel market
    • TABLE 22 MOBILE CARDIAC TELEMETRY DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.7 SMART ECG MONITORS
      • 6.2.7.1 Rising need to reduce treatment costs to drive adoption of smart/wearable ECG monitors
    • TABLE 23 SMART ECG MONITORS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3 SOFTWARE & SERVICES
    • 6.3.1 SHIFT TOWARDS AI-ENABLED ECG SOFTWARE TO SUPPORT GROWTH
    • TABLE 24 DIAGNOSTIC ECG SOFTWARE & SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)

7 DIAGNOSTIC ECG MARKET, BY LEAD TYPE

  • 7.1 INTRODUCTION
    • TABLE 25 DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2021-2028(USD MILLION)
  • 7.2 12-LEAD ECG DEVICES
    • 7.2.1 GROWING USE IN PRE-HOSPITAL AND CLINIC SETTINGS TO DRIVE MARKET GROWTH
    • TABLE 26 12-LEAD ECG DEVICES MARKET, BY REGION, 2021-2028(USD MILLION)
  • 7.3 5-LEAD ECG DEVICES
    • 7.3.1 GROWING IMPORTANCE OF PATIENT MONITORING TO BOOST ADOPTION
    • TABLE 27 5-LEAD ECG DEVICES MARKET, BY REGION, 2021-2028(USD MILLION)
  • 7.4 3-LEAD ECG DEVICES
    • 7.4.1 ABILITY TO MEET NEEDS OF MULTIPLE DIAGNOSTIC TESTS SIMULTANEOUSLY TO SUPPORT MARKET
    • TABLE 28 3-LEAD ECG DEVICES MARKET, BY REGION, 2021-2028(USD MILLION)
  • 7.5 6-LEAD ECG DEVICES
    • 7.5.1 GROWING USE OF 6-LEAD ECG DEVICES IN REMOTE PATIENT MONITORING TO FAVOR MARKET GROWTH
    • TABLE 29 6-LEAD ECG DEVICES MARKET, BY REGION, 2021-2028(USD MILLION)
  • 7.6 SINGLE-LEAD ECG DEVICES
    • 7.6.1 EASE OF USE FOR DIAGNOSIS AND QUICK RESULTS TO INCREASE USE OF SINGLE-LEAD ECG DEVICES
    • TABLE 30 SINGLE-LEAD ECG DEVICES MARKET, BY REGION, 2021-2028(USD MILLION)
  • 7.7 OTHER ECG LEAD DEVICES
    • TABLE 31 OTHER ECG LEAD DEVICES MARKET, BY REGION, 2021-2028(USD MILLION)

8 DIAGNOSTIC ECG MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 32 DIAGNOSTIC ECG MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 8.2 HOSPITALS, CLINICS, AND CARDIAC CENTERS
    • 8.2.1 INCREASING UTILIZATION OF ECG DEVICES IN HOSPITALS & CARDIAC CENTERS TO ACCELERATE MARKET GROWTH
    • TABLE 33 DIAGNOSTIC ECG MARKET FOR HOSPITALS, CLINICS, AND CARDIAC CENTERS, BY REGION, 2021-2028 (USD MILLION)
  • 8.3 AMBULATORY SURGERY CENTERS
    • 8.3.1 GROWING ADOPTION OF OUTPATIENT SURGERIES TO SUPPORT GROWTH
    • TABLE 34 DIAGNOSTIC ECG MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2021-2028 (USD MILLION)
  • 8.4 OTHER END USERS
    • TABLE 35 DIAGNOSTIC ECG MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)

9 DIAGNOSTIC ECG MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 36 DIAGNOSTIC ECG MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 26 NORTH AMERICA: DIAGNOSTIC ECG MARKET SNAPSHOT
    • TABLE 37 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 38 NORTH AMERICA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 39 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2021-2028 (USD MILLION)
    • TABLE 40 NORTH AMERICA: DIAGNOSTIC ECG MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.2.1 NORTH AMERICA: RECESSION IMPACT
    • 9.2.2 US
      • 9.2.2.1 Growing number of FDA approvals for ECG devices to support market growth
    • TABLE 41 US: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.2.3 CANADA
      • 9.2.3.1 Growing focus of government and private organizations on providing funding for research to drive market growth
    • TABLE 42 CANADA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 43 EUROPE: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 44 EUROPE: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 45 EUROPE: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2021-2028 (USD MILLION)
    • TABLE 46 EUROPE: DIAGNOSTIC ECG MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.1 EUROPE: RECESSION IMPACT
    • 9.3.2 GERMANY
      • 9.3.2.1 Germany to dominate diagnostic ECG market in Europe during forecast period
    • TABLE 47 GERMANY: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.3.3 FRANCE
      • 9.3.3.1 Rising prevalence of heart failure to drive adoption of diagnostic ECG devices
    • TABLE 48 FRANCE: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.3.4 UK
      • 9.3.4.1 Rising demand for home-based smart ECG devices to support market growth.
    • TABLE 49 UK: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.3.5 ITALY
      • 9.3.5.1 Rising incidence of heart diseases to increase use of diagnostic ECG devices
    • TABLE 50 ITALY: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.3.6 SPAIN
      • 9.3.6.1 Rising geriatric population to support market growth in Spain
    • TABLE 51 SPAIN: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.3.7 REST OF EUROPE
    • TABLE 52 REST OF EUROPE: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 27 ASIA PACIFIC: DIAGNOSTIC ECG MARKET SNAPSHOT
    • TABLE 53 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 54 ASIA PACIFIC: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 55 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2021-2028 (USD MILLION)
    • TABLE 56 ASIA PACIFIC: DIAGNOSTIC ECG MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.4.1 ASIA PACIFIC: RECESSION IMPACT
    • 9.4.2 JAPAN
      • 9.4.2.1 High healthcare expenditure and favorable reimbursement and insurance coverage to support market growth in Japan
    • TABLE 57 JAPAN: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.4.3 CHINA
      • 9.4.3.1 Government support for infrastructural improvement to drive market growth
    • TABLE 58 CHINA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.4.4 INDIA
      • 9.4.4.1 Government initiatives to propel market growth
    • TABLE 59 INDIA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.4.5 AUSTRALIA
      • 9.4.5.1 Growing adoption of telemedicine and remote patient monitoring to boost market
    • TABLE 60 AUSTRALIA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.4.6 SOUTH KOREA
      • 9.4.6.1 Rising geriatric population to propel market growth
    • TABLE 61 SOUTH KOREA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.4.7 REST OF ASIA PACIFIC
    • TABLE 62 REST OF ASIA PACIFIC: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 9.5 LATIN AMERICA
    • TABLE 63 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 64 LATIN AMERICA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 65 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2021-2028 (USD MILLION)
    • TABLE 66 LATIN AMERICA: DIAGNOSTIC ECG MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.5.1 LATIN AMERICA: RECESSION IMPACT
    • 9.5.2 BRAZIL
      • 9.5.2.1 Improving access to diagnostic services to drive growth
    • TABLE 67 BRAZIL: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.5.3 MEXICO
      • 9.5.3.1 Government support for infrastructural improvement to drive market growth
    • TABLE 68 MEXICO: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 9.5.4 REST OF LATIN AMERICA
    • TABLE 69 REST OF LATIN AMERICA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 GROWING MEDICAL COVERAGE IN REGION TO SUPPORT GROWTH
    • TABLE 70 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 71 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY LEAD TYPE, 2021-2028 (USD MILLION)
    • TABLE 72 MIDDLE EAST & AFRICA: DIAGNOSTIC ECG MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 STRATEGIES ADOPTED BY KEY PLAYERS
    • FIGURE 28 KEY DEVELOPMENTS IN DIAGNOSTIC ECG MARKET (2020-2023)
  • 10.3 REVENUE SHARE ANALYSIS
    • FIGURE 29 REVENUE SHARE ANALYSIS OF TOP FIVE PLAYERS (2019-2022)
  • 10.4 MARKET SHARE ANALYSIS
    • FIGURE 30 DIAGNOSTIC ECG MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022
  • 10.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS
    • 10.5.1 STARS
    • 10.5.2 PERVASIVE PLAYERS
    • 10.5.3 EMERGING LEADERS
    • 10.5.4 PARTICIPANTS
    • FIGURE 31 DIAGNOSTIC ECG MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
  • 10.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 DYNAMIC COMPANIES
    • 10.6.3 RESPONSIVE COMPANIES
    • 10.6.4 STARTING BLOCKS
    • FIGURE 32 DIAGNOSTIC ECG MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
  • 10.7 COMPETITIVE BENCHMARKING
    • 10.7.1 OVERALL COMPANY FOOTPRINT
    • TABLE 73 OVERALL FOOTPRINT ANALYSIS: DIAGNOSTIC ECG MARKET
    • 10.7.2 COMPANY PRODUCT FOOTPRINT
    • TABLE 74 PRODUCT FOOTPRINT ANALYSIS: DIAGNOSTIC ECG MARKET
    • 10.7.3 COMPANY REGIONAL FOOTPRINT
    • TABLE 75 REGIONAL FOOTPRINT ANALYSIS: DIAGNOSTIC ECG MARKET
  • 10.8 COMPETITIVE SCENARIO (2020-2023)
    • 10.8.1 PRODUCT LAUNCHES & APPROVALS
    • TABLE 76 DIAGNOSTIC ECG MARKET: KEY PRODUCT LAUNCHES & APPROVALS (JANUARY 2020-AUGUST 2023)
    • 10.8.2 DEALS
    • TABLE 77 DIAGNOSTIC ECG MARKET: KEY DEALS (JANUARY 2020-AUGUST 2023)
    • 10.8.3 OTHER DEVELOPMENTS
    • TABLE 78 DIAGNOSTIC ECG MARKET: OTHER DEVELOPMENTS (JANUARY 2020-AUGUST 2023)

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 11.1.1 GE HEALTHCARE
    • TABLE 79 GE HEALTHCARE: COMPANY OVERVIEW
    • FIGURE 33 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
    • 11.1.2 KONINKLIJKE PHILIPS N.V.
    • TABLE 80 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
    • FIGURE 34 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
    • 11.1.3 HILL-ROM HOLDINGS, INC. (BAXTER INTERNATIONAL INC.)
    • TABLE 81 HILL-ROM HOLDINGS, INC.: COMPANY OVERVIEW
    • FIGURE 35 HILL-ROM HOLDINGS, INC.: COMPANY SNAPSHOT (2022)
    • 11.1.4 FUKUDA DENSHI
    • TABLE 82 FUKUDA DENSHI: BUSINESS OVERVIEW
    • FIGURE 36 FUKUDA DENSHI: COMPANY SNAPSHOT (2022)
    • 11.1.5 MINDRAY MEDICAL INTERNATIONAL LIMITED
    • TABLE 83 MINDRAY MEDICAL INTERNATIONAL LIMITED: BUSINESS OVERVIEW
    • FIGURE 37 MINDRAY MEDICAL INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2021)
    • 11.1.6 NIHON KOHDEN CORPORATION
    • TABLE 84 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
    • FIGURE 38 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2022)
    • 11.1.7 OSI SYSTEMS, INC.
    • TABLE 85 OSI SYSTEMS, INC: BUSINESS OVERVIEW
    • FIGURE 39 OSI SYSTEMS, INC.: COMPANY SNAPSHOT (2022)
    • 11.1.8 BPL MEDICAL TECHNOLOGIES
    • TABLE 86 BPL MEDICAL TECHNOLOGIES: BUSINESS OVERVIEW
    • 11.1.9 SCHILLER AG
    • TABLE 87 SCHILLER AG: BUSINESS OVERVIEW
    • 11.1.10 BITTIUM
    • TABLE 88 BITTIUM: BUSINESS OVERVIEW
    • FIGURE 40 BITTIUM: COMPANY SNAPSHOT (2022)
    • 11.1.11 ACS DIAGNOSTICS
    • TABLE 89 ACS DIAGNOSTICS: BUSINESS OVERVIEW
    • 11.1.12 ALLENGERS MEDICAL SYSTEMS LTD.
    • TABLE 90 ALLENGERS MEDICAL SYSTEMS LTD: BUSINESS OVERVIEW
    • 11.1.13 BIONET
    • TABLE 91 BIONET: BUSINESS OVERVIEW
    • 11.1.14 CARDIAC INSIGHT, INC.
    • TABLE 92 CARDIAC INSIGHT, INC.: BUSINESS OVERVIEW
    • 11.1.15 BTL
    • TABLE 93 BTL: BUSINESS OVERVIEW
  • 11.2 OTHER PLAYERS
    • 11.2.1 MEDITECH EQUIPMENT CO. LTD.
    • 11.2.2 MIDMARK CORPORATION
    • 11.2.3 ALIVECOR, INC.
    • 11.2.4 VITALCONNECT
    • 11.2.5 IRHYTHM TECHNOLOGIES, INC.
    • 11.2.6 BORSAM BIOMEDICAL INSTRUMENTS CO., LTD.
    • 11.2.7 NASIFF ASSOCIATES, INC.
    • 11.2.8 VECTRACOR
    • 11.2.9 BIOMEDICAL INSTRUMENTS CO. LTD.
    • 11.2.10 LIFESIGNALS, INC.
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS